Return to Listing

1 result(s) for

PI Name Protocol # Title
Jeremy Cetnar STUDY00017685 CA209-816 - Randomized, Open-Label, Phase 3 Trial of Nivolumab plus Ipilimumab or Nivolumab plus Platinum-Doublet Chemotherapy versus Platinum-Doublet Chemotherapy in Early Stage NSCLC
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080